Cgvhd clinical trials

Explore recruiting cgvhd clinical trials.

Recruiting cgvhd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cgvhd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, multicenter, Phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD)

Belgium, Sweden, Netherlands, Germany, Denmark, Spain +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)

France, Italy, Spain, Netherlands, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy

Czechia, Finland, Austria, France, Netherlands, Ireland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab (INCA034176) and Corticosteroids as Initial Treatment for Chronic Graft-Versus Host Disease (AXemplify 357)

Italy, Denmark, Spain, Ireland, France, Germany +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Randomized, Open-Label Study Of Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Spain, Belgium, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia

Italy, Norway, Slovakia, Austria, Belgium, Germany +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

Cgvhd trials by city

Cgvhd in Toronto Cgvhd in Vancouver Cgvhd in Montreal Cgvhd in Calgary Cgvhd in Edmonton Cgvhd in Ottawa Cgvhd in Winnipeg Cgvhd in Quebec City Cgvhd in Hamilton Cgvhd in Kitchener Cgvhd in London Cgvhd in Halifax Cgvhd in New York Cgvhd in Los Angeles Cgvhd in Chicago Cgvhd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease